Colan Totte.Co.,Ltd. (7792) AI Stock Analysis

• Market Cap: ¥13.10B
• Dividend Yield: 2.08%
• Average Volume (3M): 24.35K
• Price to Earnings (P/E): 10.5
• Beta (1Y): 0.75
• Revenue Growth: 12.36%
• EPS Growth: 38.55%
• Country: JP
• Employees: 96
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Devices
• EPS (TTM): 37.79
• Shares Outstanding: 9,080,100
• 10 Day Avg. Volume: 42,950
• 30 Day Avg. Volume: 24,346
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,570.00
• Price Target Upside: 8.80% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 77 Outperform
• Price Target: ¥1,570.00 ▲(8.80% Upside)

Colan Totte.Co.,Ltd. receives a strong overall score driven by robust financial performance and attractive valuation. The technical analysis supports a bullish outlook, though some caution is warranted due to the RSI indicating potential overbought conditions.

Colan Totte.Co.,Ltd. Business Overview & Revenue Model

Company Description

Colan Totte Co., Ltd. is a Japanese company that specializes in the development, production, and sale of health and wellness products. The company is renowned for its innovative line of magnetic and electrical therapy devices, which are designed to promote health and enhance the well-being of its users. Colan Totte's product offerings include magnetic necklaces, bracelets, and other accessories that integrate therapeutic benefits, catering to a diverse consumer base seeking alternative health solutions.

How the Company Makes Money

Colan Totte Co., Ltd. generates revenue through the sale of its health and wellness products, primarily focusing on magnetic therapy devices. The company markets its products through various distribution channels, including retail stores, online platforms, and direct sales. Key revenue streams include direct consumer sales and partnerships with retailers and distributors who carry their products. Significant factors contributing to its earnings include its strong brand reputation, innovation in product design, and a growing global demand for alternative and complementary health therapies.

Colan Totte.Co.,Ltd. Financial Statement Overview

Summary

Colan Totte.Co.,Ltd. demonstrates a strong financial position with significant revenue growth, high profitability margins, and stable balance sheet metrics. However, fluctuations in cash flow metrics introduce some uncertainty.

Income Statement

Colan Totte.Co.,Ltd. shows strong financial performance with robust revenue growth and improving profitability. The TTM (Trailing-Twelve-Months) revenue growth rate is impressive, indicating a positive trajectory. The gross profit margin and net profit margin are healthy, showcasing efficient cost management and operational success. Both EBIT and EBITDA margins are strong, reinforcing the company's profitability.

Balance Sheet

The balance sheet reflects solid financial stability with a low debt-to-equity ratio, suggesting prudent leverage management. The company has a high equity ratio, indicating a strong capital structure with significant shareholder investment. Return on Equity (ROE) is commendable, highlighting effective utilization of equity in generating profits.

Cash Flow

While the operating cash flow is substantial, the free cash flow growth has fluctuated, reflecting potential volatility in capital expenditures. The operating cash flow to net income ratio suggests that cash generation is in line with profitability. However, the absence of recent free cash flow data in TTM limits the analysis of cash flow resilience.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.28B	5.94B	5.41B	4.66B	3.71B	2.89B
Gross Profit	4.21B	3.97B	3.45B	3.04B	2.46B	1.82B
EBITDA	1.78B	1.57B	1.10B	1.02B	691.13M	566.85M
Net Income	1.26B	1.02B	645.02M	610.45M	420.50M	324.81M
Balance Sheet
Total Assets	6.00B	5.43B	4.88B	4.10B	3.62B	2.32B
Cash, Cash Equivalents and Short-Term Investments	2.00B	1.76B	1.79B	1.34B	1.55B	507.34M
Total Debt	5.34M	8.69M	1.27M	270.48M	439.84M	912.09M
Total Liabilities	1.41B	1.32B	1.61B	1.36B	1.38B	1.44B
Stockholders Equity	4.58B	4.11B	3.27B	2.75B	2.24B	886.03M
Cash Flow
Free Cash Flow	0.00	357.26M	867.34M	75.48M	597.37M	317.68M
Operating Cash Flow	0.00	883.77M	955.70M	148.09M	637.27M	378.76M
Investing Cash Flow	0.00	-736.91M	-83.80M	-80.38M	-51.45M	-59.48M
Financing Cash Flow	0.00	-180.15M	-410.10M	-274.23M	452.40M	-236.52M

Colan Totte.Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1443.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7792, the sentiment is Neutral. The current price of 1443 is below the 20-day moving average (MA) of 1484.95, below the 50-day MA of 1451.98, and above the 200-day MA of 1205.12, indicating a neutral trend. The MACD of -2.12 indicates Positive momentum. The RSI at 44.76 is Neutral, neither overbought nor oversold. The STOCH value of 28.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7792.

Colan Totte.Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6823	79 Outperform	¥32.23B	10.54		2.49%	7.99%	28.81%
5187	78 Outperform	¥8.96B	12.00		3.76%	3.38%	88.65%
7792	77 Outperform	¥13.10B	10.45		2.08%	12.36%	38.55%
7963	75 Outperform	¥8.95B	11.58		1.92%	9.07%	43.42%
6678	74 Outperform	¥16.94B	16.25		3.42%	-8.07%	-38.21%
7600	56 Neutral	¥13.69B	10.23		2.88%	4.84%	-148.94%
Sector *	51 Neutral	$7.85B	-0.21	-41.41%	2.22%	22.81%	-2.01%